Código QR (código de barras bidimensional)

Variant allele frequency as a predictor of treatment response to osimertinib in EGFR-mutated NSCLC

BackgroundOsimertinib has been approved as a treatment option for epidermal growth factor receptor (EGFR) mutated non-small cell lung cancer (NSCLC). However, despite the identification of common mutations, there are still no additional pathological factors that can be used to predict treatment resp...

Fuld beskrivelse

Na minha lista:
Principais autores: Walid Shalata, Bilal Krayim, Asmah Miari, Abed Agbarya, Nir Peled, Yulia Dudnik, Ahron Yehonatan Cohen, Amichay Meirovitz, Natalie Maimon Rabinovich, Alexander Yakobson, Firas Abu Akar, Ronen Brenner
Format: Artigo
Sprog:Inglês
Udgivet: Frontiers Media S.A. 2026-04-01
Serier:Frontiers in Molecular Biosciences
Fag:
EGFR
non-small cell lung cancer
osimertinib
overall survival
progression-free survival
variant allele frequency
Online adgang:https://www.frontiersin.org/articles/10.3389/fmolb.2026.1822285/full
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker